Managing Patients With Metastatic Prostate Cancer: Who Takes the Lead?

Trends in Urology & Men's Health
doi 10.1002/tre.591
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

STAMPEDE Trial and Patients With Non-Metastatic Prostate Cancer – Authors' Reply

The Lancet
Medicine
2016English

Immune Analysis of Radium-223 in Patients With Metastatic Prostate Cancer

Clinical Genitourinary Cancer
OncologyUrology
2018English

Utility of Percutaneous Liver Ablation in Patients With Metastatic Prostate Cancer

Journal of Vascular and Interventional Radiology
Nuclear MedicineRadiologyCardiologyCardiovascular MedicineImagingMedicine
2016English

89Zr-huJ591 Immuno-Pet Imaging in Patients With Advanced Metastatic Prostate Cancer

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2014English

Healthcare Pathway and Costs Analysis in Patients With Metastatic Prostate Cancer (MPC)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Who Takes the Lead? Investigating the Reciprocal Relationship Between Organizational and News Agendas

Communication Research
CommunicationLanguageLinguistics
2018English

Indirect Treatment Comparison of Cabazitaxel for Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Been Previously Treated With a Docetaxel-Containing Regimen

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

PCN120 Quality of Life Among German Patients With Metastatic Castration-Resistant Prostate Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Metastatic Prostate Cancer With Highest Reported PSA Level

Acta Medica Marisiensis
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy